Scientific Affairs Team

Apex has exceptional experience in designing strategies and executing complex biomarker studies that can provide supporting data to inform key go/no-go decisions. We have leveraged the NIMH Research Domain Criteria (RDoC)-like strategy with many molecules, working directly with Sponsors and various academic key opinion leaders (KOLs) in adapting novel paradigms using both electrophysiology and neuroimaging. Drs. Ereshefsky and English are innovators in the application of translational drug development tools, and are adept at integrating state-of-the-art technologies within a single study for corroborative and correlative analyses.